Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 4651 AL 4665

Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease

Yahi N, Di Scala C, Chahinian H, Fantini J.

Glycoconj J. 2022 Feb;39(1):1-11. doi: 10.1007/s10719-021-10012-0. Epub 2021 Jul 30.

[Causes of visual hallucinations in Parkinson's disease]

Diederich NJ.

Nervenarzt. 2022 Apr;93(4):392-401. doi: 10.1007/s00115-021-01165-2. Epub 2021 Aug 3.

Occupational pesticide exposure, cancer and chronic neurological disorders: A systematic review of epidemiological studies in greenspace workers

de Graaf L, Boulanger M, Bureau M, Bouvier G, Meryet-Figuiere M, Tual S, Lebailly P, Baldi I.

Environ Res. 2022 Jan;203:111822. doi: 10.1016/j.envres.2021.111822. Epub 2021 Aug 2.

Traumatic Brain Injury and Risk of Neurodegenerative Disorder

Brett BL, Gardner RC, Godbout J, Dams-O'Connor K, Keene CD.

Biol Psychiatry. 2022 Mar 1;91(5):498-507. doi: 10.1016/j.biopsych.2021.05.025. Epub 2021 Jun 2.

Risk factors of impulsive-compulsive behaviors in PD patients: a meta-analysis

Cao L, Xu T, Zhao G, Lv D, Lu J, Zhao G.

J Neurol. 2022 Mar;269(3):1298-1315. doi: 10.1007/s00415-021-10724-1. Epub 2021 Aug 9.

Remote smartphone monitoring of Parkinson's disease and individual response to therapy

Omberg L, Chaibub Neto E, Perumal TM, Pratap A, Tediarjo A, Adams J, Bloem BR, Bot BM, Elson M, Goldman SM, Kellen MR, Kieburtz K, Klein A, Little MA, Schneider R, Suver C, Tarolli C, Tanner CM, Trister AD, Wilbanks J, Dorsey ER, Mangravite LM.

Nat Biotechnol. 2022 Apr;40(4):480-487. doi: 10.1038/s41587-021-00974-9. Epub 2021 Aug 9.

Effectiveness of gait aid prescription for improving spatiotemporal gait parameters and associated outcomes in community-dwelling older people: a systematic review

Lee DA, Dissanayaka T, Burton E, Meyer C, Hunter SW, Suttanon P, Ekegren CL, Stout JC, Dawes H, Hill KD.

Disabil Rehabil. 2022 Oct;44(21):6139-6154. doi: 10.1080/09638288.2021.1958930. Epub 2021 Aug 10.

The Essential Role of Epigenetic Modifications in Neurodegenerative Diseases with Dyskinesia

Qi Z, Li J, Li M, Du X, Zhang L, Wang S, Xu B, Liu W, Xu Z, Deng Y.

Cell Mol Neurobiol. 2022 Nov;42(8):2459-2472. doi: 10.1007/s10571-021-01133-z. Epub 2021 Aug 12.

PARkinson's: From cellular mechanisms to potential therapeutics

Lengyel-Zhand Z, Puentes LN, Mach RH.

Pharmacol Ther. 2022 Feb;230:107968. doi: 10.1016/j.pharmthera.2021.107968. Epub 2021 Aug 12.

Multimodal retinal imaging to detect and understand Alzheimer's and Parkinson's disease

Moons L, De Groef L.

Curr Opin Neurobiol. 2022 Feb;72:1-7. doi: 10.1016/j.conb.2021.07.007. Epub 2021 Aug 14.

Place of Death of Geriatric Population in Turkey: A 7-Year Observational Study

Ceylan S, Guner Oytun M, Okyar Bas A, Kahyaoglu Z, Dogu BB, Cankurtaran M, Halil MG.

J Palliat Care. 2022 Jan;37(1):18-25. doi: 10.1177/08258597211036579. Epub 2021 Aug 17.

A Systematic Review and Meta-analysis of Iowa Oral Performance Instrument Measures in Persons with Parkinson's Disease Compared to Healthy Adults

Pitts LL, Cox A, Morales S, Tiffany H.

Dysphagia. 2022 Feb;37(1):99-115. doi: 10.1007/s00455-021-10254-y. Epub 2021 Aug 17.

Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease

Meloni M, Figorilli M, Carta M, Tamburrino L, Cannas A, Sanna F, Defazio G, Puligheddu M.

Sleep Breath. 2022 Sep;26(3):1023-1031. doi: 10.1007/s11325-021-02417-w. Epub 2021 Aug 17.

Early implementation of intended exercise improves quality of life in Parkinson's disease patients

Yang Y, Chen L, Yao J, Wang N, Liu D, Wang Y, Liu D, Wu W, Jiang T, Wang Z.

Neurol Sci. 2022 Mar;43(3):1761-1767. doi: 10.1007/s10072-021-05530-6. Epub 2021 Aug 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias